Navigation Links
WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market
Date:7/1/2008

WorldHeart Announces Resignation of Chief Financial Officer

OAKLAND, Calif., July 1 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT) -- World Heart Corporation ("WorldHeart" or the "Corporation") announced today that, on June 25, 2008, WorldHeart received a notice from the NASDAQ Stock Market stating that the Corporation does not comply with Marketplace Rule 4310(c)(7)(A) (the "Rule"). This rule requires the Corporation to maintain a minimum market value of publicly held shares ("MVPHS") of $1,000,000. Therefore, in accordance with Marketplace Rule 4310(c)(8)(B), the Corporation will be provided 90 calendar days, or until September 23, 2008, to regain compliance. If, at any time before September 23, 2008, the MVPHS of the Corporation's common shares are $1,000,000 or more for a minimum of 10 consecutive trading days, Staff will provide a written notification that the Corporation complies with the Rule. If compliance with this Rule cannot be demonstrated by September 23, 2008, Staff will provide a written notification that the Company's securities will be delisted. At that time, the Corporation may appeal Staff's determination to a Listing Qualifications Panel.

Separately, effective July 1, 2008, WorldHeart announced that David Pellone has resigned as an employee of the Corporation, but will continue as a consultant to the Corporation until approximately September 30, 2008. As approved by WorldHeart's Board of Directors, Mr. Pellone will be acting Vice President, Finance and Chief Financial Officer during his time as a consultant. The Corporation will commence the process to find a new Chief Financial Officer to allow for a smooth transition. The WorldHeart Board and Jal S. Jassawalla, WorldHeart's President and Chief Executive Officer, thank David for his service, especially his dedication during the recapitalization efforts recently announced. "We appreciate David's contributions and look forward to continuing to work with him during this transition period," said Mr. Jassawalla.

About World Heart Corporation

WorldHeart is a developer of mechanical circulatory support systems with broad-based next-generation technologies. The Company is headquartered in Oakland, California, USA with additional facilities in Salt Lake City, Utah and Herkenbosch, The Netherlands. WorldHeart's registered office is Ottawa, Ontario, Canada.

Any forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include any statements regarding the Corporation's expectations with respect to submitting a specific plan to achieve and sustain compliance with The NASDAQ Capital Market listing requirements and the Corporation's ability to maintain its NASDAQ listing if the plan is not accepted by NASDAQ, as well as other statements that can be identified by the use of forward-looking language, such as "believes," "feels," "expects," "may," "will," "should," "seeks," "plans," "anticipates," or "intends" or the negative of those terms, or by discussions of strategy or intentions. Investors are cautioned that all forward-looking statements involve risk and uncertainties, including without limitation: the Corporation's immediate need for additional capital, risks in product development and market acceptance of and demand for the Company's products; possible delisting from the NASDAQ Stock Market if compliance with the listing standards, including the minimum Stockholders' Equity Standard is not regained; and other risks detailed in the Corporation's filings with the U.S. Securities and Exchange Commission, including without limitation its Annual Report on Form 10-KSB for the year ended December 31, 2007.

THIS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICTITATION OF AN OFFER TO BUY ANY SECURITY. THE SHARES OFFERED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR ANY STATE THEREOF ABSENT REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR AN APPLICABLE EXEMPTION FROM REGISTRATION REQUIREMENTS.


'/>"/>
SOURCE World Heart Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Announces Voluntary Delisting from the Toronto Stock Exchange
2. WorldHeart Announces Possible Delisting Action by NASDAQ
3. WorldHeart Notified of TSX Delisting Review
4. WorldHeart Appoints David Pellone Chief Financial Officer
5. Researcher receives $4 million from RWJ Foundation to study health quality reform project
6. ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business
7. SleepRight(R) Dental Guard Receives FDA Clearance
8. Crystalens HD(TM) Receives FDA Approval
9. Weight Watchers Receives Adverse U.K. VAT Ruling
10. Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year
11. Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: